StockClub

BIOVF

BIOVFSwedish Orphan Biovitrum AB (publ)$ --
Swedish Orphan Biovitrum AB (publ)

Swedish Orphan Biovitrum AB (publ)

BIOVF

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
7,801M SEK
YoY +4.9%
Operating Income
2,358M SEK
YoY +41.9%
Net Income
1,857M SEK
YoY +33.0%
EPS
5.38SEK
YoY +32.2%

Revenue

SEK28.2B
FY2024 Q1SEK6.3B
SEK6.3B
Q1
FY2024 Q2SEK11.7B
SEK11.7B
Q2
FY2024 Q3SEK18.6B
SEK18.6B
Q3
FY2024 Q4SEK26B
SEK26B
Q4
FY2025 Q1SEK6.5B
SEK6.5B
Q1
FY2025 Q2SEK12.6B
SEK12.6B
Q2
FY2025 Q3SEK20.4B
SEK20.4B
Q3
FY2025 Q4SEK28.2B
SEK28.2B
Q4
Actual
+SEK2.1B (+8.2%)

Net Income

SEK493.3M
FY2024 Q1SEK800M
SEK800M
Q1
FY2024 Q2SEK1B
SEK1B
Q2
FY2024 Q3SEK2.5B
SEK2.5B
Q3
FY2024 Q4SEK3.9B
SEK3.9B
Q4
FY2025 Q1SEK875M
SEK875M
Q1
FY2025 Q2SEK1.5B
SEK1.5B
Q2
FY2025 Q3SEK-1.4B
SEK-1.4B
Q3
FY2025 Q4SEK493.3M
SEK493.3M
Q4
Actual
SEK-3.4B (-87.3%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020BEAT
Actual:SEK15.3B
Est:SEK15.1B
FY2020BEAT
SEK15.3B
FY2021BEAT
Actual:SEK15.5B
Est:SEK15.3B
FY2021BEAT
SEK15.5B
FY2022BEAT
Actual:SEK18.8B
Est:SEK18B
FY2022BEAT
SEK18.8B
FY2023BEAT
Actual:SEK22.1B
Est:SEK22B
FY2023BEAT
SEK22.1B
FY2024BEAT
Actual:SEK26B
Est:SEK25.8B
FY2024BEAT
SEK26B
FY2025MISS
Actual:SEK28.2B
Est:SEK28.3B
FY2025MISS
SEK28.2B

Analyst Estimates